A study in Postᶒpy adds to the growing evidence of a link between insulin and carbohydrate metabolism in the etiology and severity of acne vulgaris. While the clinical evidence on this connection is still disputed, the majority of recent studies has pointed to a significant connection between the condition and insulin levels.
Some of the current options for managing COPD include one fixed-dose combination product, as well as combinations with an inhaled steroid, but the experts discuss here why one size does not fit all in terms of treating the inflammation in COPD with steroids.
There appears to be a positive correlation between higher antibiotic use and the development of type 2 diabetes, according to a study published in The Journal of Clinical Endocrinology & Metabolism.
The panelists note that not all COPD patients are the same, and agree that exacerbators are important, but there may be differentiations in the exacerbators that may ultimately lead to different and better therapies.
Clinicians are urged not to treat central sleep apnea in heart failure patients with the adaptive servo-ventilation (ASV) therapy, which was reported to increase mortality in heart failure patients.
New York City researchers report that a leadless cardiac pacemaker (Nanostim/St. Jude Medical) implanted non-surgically via a catheter through the femoral vein, had a better safety record than conventional devices. But it has other limitations.
Better understanding the relationship between bipolar disorder (BD) and circadian cycles can help establish new treatment protocols and treatment modalities, according to a review in the Journal of Affective Disorders.
The stress of working long hours is more likely to lead to a stroke than a heart attack, UK researchers report.
The first real-world study of its kind revealed that rivaroxaban, marketed as Xarelto, can reduce the risk of stroke and major bleeding in patients with atrial fibrillation (AF) – a group that is five times more likely to suffer a stroke compared to the general population.